Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.715,00
0,35%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Zealand Pharma AS (ZEAL) Zealand Pharma AS (ZEAL) Notizie

ZEAL

Zealand Pharma AS (ZEAL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZEAL
DataOraFonteTitoloSimboloCompagnia
10/11/202215:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Nine Months of 2022NASDAQ:ZEALZealand Pharma AS
08/11/202214:30GlobeNewswire Inc.Zealand Pharma to Participate in Upcoming Investor ConferencesNASDAQ:ZEALZealand Pharma AS
03/11/202209:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
01/11/202217:00GlobeNewswire Inc.Zealand Pharma Announces Presentations at The Obesity Society Annual MeetingNASDAQ:ZEALZealand Pharma AS
11/10/202217:05GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Polar CapitalNASDAQ:ZEALZealand Pharma AS
10/10/202217:12GlobeNewswire Inc.Zealand Pharma major shareholder announcement: Van Herk InvestmentsNASDAQ:ZEALZealand Pharma AS
07/10/202208:41GlobeNewswire Inc.Zealand Pharma completes registration of capital increaseNASDAQ:ZEALZealand Pharma AS
04/10/202222:07GlobeNewswire Inc.Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 millionNASDAQ:ZEALZealand Pharma AS
04/10/202217:05GlobeNewswire Inc.Zealand Pharma announces directed issue and private placement of approximately 4.5m new sharesNASDAQ:ZEALZealand Pharma AS
30/09/202222:15TipRanksNeedham Sticks to Their Buy Rating for Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
30/09/202222:00GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at September 30, 2022NASDAQ:ZEALZealand Pharma AS
30/09/202213:41TipRanksZealand Pharma’s (NASDAQ:ZEAL) Phase 3 SBS Trial Sees Positive ResultsNASDAQ:ZEALZealand Pharma AS
30/09/202212:15GlobeNewswire Inc.Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide in Patients with Short Bowel Syndrome (EASE 1)NASDAQ:ZEALZealand Pharma AS
21/09/202214:15GlobeNewswire Inc.Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)NASDAQ:ZEALZealand Pharma AS
19/09/202208:00GlobeNewswire Inc.Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE MeetingNASDAQ:ZEALZealand Pharma AS
14/09/202212:11TipRanksAnalysts’ Top Healthcare Picks: Zealand Pharma (ZEAL), POINT Biopharma Global (PNT)NASDAQ:ZEALZealand Pharma AS
13/09/202222:05GlobeNewswire Inc.Zealand Pharma grants warrants to employees in DenmarkNASDAQ:ZEALZealand Pharma AS
08/09/202222:05GlobeNewswire Inc.Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee WarrantsNASDAQ:ZEALZealand Pharma AS
07/09/202217:00GlobeNewswire Inc.Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare ConferenceNASDAQ:ZEALZealand Pharma AS
07/09/202208:00GlobeNewswire Inc.Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)NASDAQ:ZEALZealand Pharma AS
31/08/202221:30GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at August 31, 2022NASDAQ:ZEALZealand Pharma AS
24/08/202210:30GlobeNewswire Inc.Zealand Pharma Appoints Henriette Wennicke as Chief Financial OfficerNASDAQ:ZEALZealand Pharma AS
11/08/202219:30TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Trevena (TRVN), Zealand Pharma (ZEAL)NASDAQ:ZEALZealand Pharma AS
11/08/202215:00GlobeNewswire Inc.Zealand Pharma Announces Financial Results for the First Half of 2022NASDAQ:ZEALZealand Pharma AS
08/08/202222:30GlobeNewswire Inc.Updated notice to holders of ADSs regarding termination of Deposit AgreementNASDAQ:ZEALZealand Pharma AS
08/08/202222:05GlobeNewswire Inc.Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select MarketNASDAQ:ZEALZealand Pharma AS
04/08/202215:00GlobeNewswire Inc.Zealand Pharma Hosts Conference Call on August 11 at 4 pm CET (10am ET) to Present Second Quarter Results for 2022NASDAQ:ZEALZealand Pharma AS
14/07/202212:45TipRanksZealand Pharma (ZEAL) Receives a Buy from NeedhamNASDAQ:ZEALZealand Pharma AS
30/06/202215:44GlobeNewswire Inc.Total number of shares and voting rights in Zealand Pharma at June 30, 2022NASDAQ:ZEALZealand Pharma AS
15/06/202222:00GlobeNewswire Inc.Transactions in Zealand Pharma A/S securities by persons discharging managerial responsibilitiesNASDAQ:ZEALZealand Pharma AS
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ZEAL

La tua Cronologia

COIN
0XBTCUST
0xBitcoin Token
USOTC
EXSR
Exchange Bank Santa Rosa (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network